Article
SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis.
PloS one - 1 Jan 2017
Zainabadi Kayvan, Liu Cassie J, Caldwell Alison L M, Guarente Leonard
Abstract excerpt
Overexpression or pharmacological activation of SIRT1 has been shown to extend the lifespan of mice and protect against aging-related diseases. Here we show that pharmacological activation of SIRT1 protects in two models of osteoporosis. Ovariectomized female mice and aged male mice, models for post-menopausal and aging-related osteoporosis, respectively, show significant improvements in bone mass upon treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
